Drugs / Caphosol

Trials 4

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial · 1 missed
Phase 2 NCT02807337 Aug 2016 → Dec 2019 cancer Tampere University Hospital Completed Missed primary
Phase 32 trials
Phase 3 NCT02539342 Oct 2016 → Mar 2017 chemotherapy-induced oral mucositis Medical College of Wisconsin Terminated No outcome recorded Stop: Business
Phase 3 NCT01305200 Mar 2011 → Jun 2015 Burkitt lymphoma, Hodgkins lymphoma, childhood acute lymphoblastic leukemia, childhood acute myeloid leukemia +11 Children's Oncology Group Completed No outcome recorded
Phase not applicable1 trial
— NCT01046812 Sep 2009 → Dec 2011 — New York Head & Neck Institute Completed No outcome recorded
Comparator or background therapy4 trials
Phase 1 NCT03399331 Background Jul 2017 → Dec 2021 chemotherapy-induced oral mucositis, leukemia American University of Beirut Medical Center Completed No outcome recorded
Phase 1/2 NCT02589145 Background Jun 2016 → Apr 2019 lymphoma M.D. Anderson Cancer Center Terminated No outcome recorded Stop: Enrollment
Phase 1/2 NCT02701673 Background Jun 2016 → Jun 2019 lymphoma M.D. Anderson Cancer Center Withdrawn No outcome recorded
Phase 2 NCT02114502 Background Sep 2014 → Sep 2018 plasma cell myeloma M.D. Anderson Cancer Center Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Caphosol “Control at our institution is 5cc sodium bicarbonate, 5cc rinsidin and 5cc of mycostatin 4 times daily for children. For adults it is Caphosol in the BMT unit and in the Basile...” NCT03399331 ↗
7

“This randomized phase III trial is studying how well Caphosol rinse works in preventing mucositis in young patients undergoing autologous or donor stem cell transplant.” NCT01305200 ↗

NCT01046812 ↗

NCT02114502 ↗

NCT02807337 ↗

NCT02539342 ↗

NCT02589145 ↗

NCT02701673 ↗

Modality Other / unclassified “Caphosol is a topical oral agent of supersaturated calcium phosphate rinse indicated for dry mouth” NCT01046812 ↗
Route Oral “Caphosol 2-4 times daily oral rinse” NCT01046812 ↗